학술논문
Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination
Document Type
Patent
Author
Source
Subject
Language
Abstract
Use of intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein and/or a nucleic acid molecule encoding for the intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein, of any species, for the preparation of a medicament, preferably a vaccine, for the treatment and/or prevention of a tumor in a subject, preferably a lymphoma.